| 000 | 01052 a2200277 4500 | ||
|---|---|---|---|
| 005 | 20250515161116.0 | ||
| 264 | 0 | _c20100913 | |
| 008 | 201009s 0 0 eng d | ||
| 022 | _a1473-4877 | ||
| 024 | 7 |
_a10.1185/03007990802707139 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aSehouli, Jalid | |
| 245 | 0 | 0 |
_aCurrent role and future aspects of topotecan in relapsed ovarian cancer. _h[electronic resource] |
| 260 |
_bCurrent medical research and opinion _cMar 2009 |
||
| 300 |
_a639-51 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't; Review | ||
| 650 | 0 | 4 |
_aAntineoplastic Agents _xadministration & dosage |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aOvarian Neoplasms _xdrug therapy |
| 650 | 0 | 4 | _aRecurrence |
| 650 | 0 | 4 |
_aTopotecan _xadministration & dosage |
| 700 | 1 | _aOskay-Ozcelik, Gülten | |
| 773 | 0 |
_tCurrent medical research and opinion _gvol. 25 _gno. 3 _gp. 639-51 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1185/03007990802707139 _zAvailable from publisher's website |
| 999 |
_c18674466 _d18674466 |
||